Search results
Results from the WOW.Com Content Network
One stock that just can't seem to catch a break of late is Pfizer (NYSE: PFE). Given how well Pfizer has performed in recent years due to its COVID-19 vaccine and pill (its revenue topped $100 ...
Here are three no-brainer biotech stocks to buy with $200 right now. Biotech stocks usually appeal more to aggressive growth investors, while value investors typically prefer to look elsewhere.
Analysts expect share prices to increase from $2.44 to $3.50 in the next 12 months, and three of the five watching the stock rate it a "strong buy" or "buy." What are the best stocks under $2?
With this, pandemic-related drug stocks will likely remain hot. Think vaccine stocks, such as Moderna (NASDAQ:MRNA) and Pfizer (NYSE:PFE), or even stocks in companies coming out with Covid-19 ...
[42] [43] Kramer's previous significant sale of company stock under a SEC Rule 10b-5 plan was in April 2016, and several other Emergent executives also sold stock at that time. The share price subsequently fell, and a lawsuit was filed by investors regarding misrepresentation of the size of the U.S. government's order for anthrax vaccine from ...
Thanks to fractional shares and commission-free trading, anyone can invest these days, whether you've got $200 or $2 million. While the stock has performed well in anticipation of asset-cap ...
GOOG Free Cash Flow (Quarterly) data by YCharts So, Alphabet remains a top stock to buy and hold well beyond next year. 2. Veeva Systems. Veeva Systems provides cloud-related services to companies ...
Ally stock has been under pressure, and it plunged in September after it disclosed that defaults have been worse than expected. Its recent update was that auto loan defaults are high at 2.24%, ...